BMG PHARMA S.P.A. – Trademark Portfolio
Entity Type: 98
BMG PHARMA S.P.A. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include LIPOHYAL, IALUVANCE, HYALUROMIMETHIC, and HYALUROMIMETHIC MIOH.
Viale Francesco Restelli 1
I-20124 Milano (MI)
Showing of trademarks Trademarks
Trademark Classifications
BMG PHARMA S.P.A.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Frequently Asked Questions
How many trademarks does BMG PHARMA S.P.A. have?
BMG PHARMA S.P.A. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does BMG PHARMA S.P.A. file in?
BMG PHARMA S.P.A. files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are BMG PHARMA S.P.A.'s most well-known trademarks?
BMG PHARMA S.P.A.'s registered trademark portfolio includes well-known marks such as LIPOHYAL, IALUVANCE, HYALUROMIMETHIC, and HYALUROMIMETHIC MIOH. These are among 4 currently registered trademarks in the portfolio.
What is BMG PHARMA S.P.A.'s trademark registration success rate?
BMG PHARMA S.P.A. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.